x
Filter:
Filters applied
- Microbiology
- Clarke, Bradley RRemove Clarke, Bradley R filter
- Liu, BinRemove Liu, Bin filter
Publication Date
Please choose a date range between 2018 and 2019.
Keyword
- lipopolysaccharide (LPS)2
- ABC transporter1
- bacterial outer membrane1
- carbohydrate structure1
- carbohydrate-binding module (CBM)1
- glycan export1
- glycobiology1
- glycolipid1
- glycosyltransferase1
- Gram-negative bacteria1
- Klebsiella pneumonia1
- membrane transport1
- nuclear magnetic resonance (NMR)1
- O antigen1
- O-antigen polysaccharide1
- polysaccharide1
- polysaccharide structure1
- serotyping1
Microbiology
2 Results
- ArticleOpen Access
Substrate recognition by a carbohydrate-binding module in the prototypical ABC transporter for lipopolysaccharide O-antigen from Escherichia coli O9a
Journal of Biological ChemistryVol. 294Issue 41p14978–14990Published online: August 15, 2019- Evan Mann
- Steven D. Kelly
- M. Sameer Al-Abdul-Wahid
- Bradley R. Clarke
- Olga G. Ovchinnikova
- Bin Liu
- and others
Cited in Scopus: 8Escherichia coli serotype O9a provides a model for export of lipopolysaccharide (LPS) O-antigen polysaccharide (O-PS) via ABC transporters. In O9a biosynthesis, a chain-terminator enzyme, WbdD, caps the nonreducing end of the glycan with a methylphosphate moiety and thereby establishes chain-length distribution. A carbohydrate-binding module (CBM) in the ABC transporter recognizes terminated glycans, ensuring that only mature O-PS is exported and incorporated into LPS. Here, we addressed two questions arising from this model. - MicrobiologyOpen Access
Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae
Journal of Biological ChemistryVol. 293Issue 13p4666–4679Published online: February 12, 2018- Bradley R. Clarke
- Olga G. Ovchinnikova
- Steven D. Kelly
- Monica L. Williamson
- Jennifer E. Butler
- Bin Liu
- and others
Cited in Scopus: 24Klebsiella pneumoniae is a major health threat. Vaccination and passive immunization are considered as alternative therapeutic strategies for managing Klebsiella infections. Lipopolysaccharide O antigens are attractive candidates because of the relatively small range of known O-antigen polysaccharide structures, but immunotherapeutic applications require a complete understanding of the structures found in clinical settings. Currently, the precise number of Klebsiella O antigens is unknown because available serological tests have limited resolution, and their association with defined chemical structures is sometimes uncertain.